Literature DB >> 25110155

Screening for five prevalent mutations of SLC25A13 gene in Guangdong, China: a molecular epidemiologic survey of citrin deficiency.

Zhan-Hui Zhang1, Zhi-Gang Yang, Feng-Ping Chen, Atsuo Kikuchi, Zhen-Huan Liu, Li-Zhen Kuang, Wei-Ming Li, Yuan-Zong Song, Shigeo Kure, Takeyori Saheki.   

Abstract

Citrin is the liver-type aspartate/glutamate carrier isoform 2 (AGC2) encoded by SLC25A13 gene, playing important roles in the urea cycle and the malate-aspartate shuttle. Citrin deficiency (CD) has proven a disease entity with high prevalence in south China, including Guangdong with the largest population, but CD epidemiology in this province has not been well characterized. This study aims to screen for five prevalent SLC25A13 mutations, c.851_854del (p.R284fs286X), c.1638_1660dup (p.A554fs570X), c.615+5G>A (p.A206fs212X), IVS16ins3kb (p.A584fs585X) and c.1399C>T (p.R467X), to calculate the mutation carrier rate in Guangdong. A total of 2,428 used blood samples for health examination were collected as the research subjects, including 1,558 from 5 cities in the Pearl River Delta area and the remaining 870 from 4 peripheral cities, and the 5 mutations screened using High Resolution Melting Assay and HybProbe assay. A total of 52 carriers were detected, including 2 carriers of a novel c.1420G>A (p.V474M) mutation that impairs citrin function, as judged by the functional analysis in the yeast system. The carrier rate was higher in Pearl River Delta area than that in the peripheral cities (26/1,558 vs. 26/870, with χ(2) = 4.639 and P < 0.05). The carrier rate was around 1/47 (52/2,428), theoretically with the CD morbidity of 1/8,800 and the number of CD patients over 11,800 in Guangdong population. This study has provided primary epidemiologic data for the evaluation of CD effect in Guangdong province. Moreover, the newly identified c.1420G>A mutation that impairs AGC2 function has enriched the mutation spectrum of human SLC25A13 gene.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25110155     DOI: 10.1620/tjem.233.275

Source DB:  PubMed          Journal:  Tohoku J Exp Med        ISSN: 0040-8727            Impact factor:   1.848


  5 in total

1.  Molecular diagnosis of pediatric patients with citrin deficiency in China: SLC25A13 mutation spectrum and the geographic distribution.

Authors:  Wei-Xia Lin; Han-Shi Zeng; Zhan-Hui Zhang; Man Mao; Qi-Qi Zheng; Shu-Tao Zhao; Ying Cheng; Feng-Ping Chen; Wang-Rong Wen; Yuan-Zong Song
Journal:  Sci Rep       Date:  2016-07-11       Impact factor: 4.379

2.  Molecular diagnosis of citrin deficiency in an infant with intrahepatic cholestasis: identification of a 21.7kb gross deletion that completely silences the transcriptional and translational expression of the affected SLC25A13 allele.

Authors:  Zhan-Hui Zhang; Wei-Xia Lin; Qi-Qi Zheng; Li Guo; Yuan-Zong Song
Journal:  Oncotarget       Date:  2017-08-03

3.  Sodium Taurocholate Cotransporting Polypeptide (NTCP) Deficiency Hidden Behind Citrin Deficiency in Early Infancy: A Report of Three Cases.

Authors:  Hui Lin; Jian-Wu Qiu; Yaqub-Muhammad Rauf; Gui-Zhi Lin; Rui Liu; Li-Jing Deng; Mei Deng; Yuan-Zong Song
Journal:  Front Genet       Date:  2019-11-07       Impact factor: 4.599

4.  Citrin deficiency mimicking mitochondrial depletion syndrome.

Authors:  S C Grünert; A Schumann; P Freisinger; S Rosenbaum-Fabian; M Schmidts; A J Mueller; S Beck-Wödl; T B Haack; H Schneider; H Fuchs; U Teufel; G Gramer; L Hannibal; U Spiekerkoetter
Journal:  BMC Pediatr       Date:  2020-11-11       Impact factor: 2.125

5.  Molecular epidemiologic study of citrin deficiency by screening for four reported pathogenic SLC25A13 variants in the Shaanxi and Guangdong provinces, China.

Authors:  Wei-Xia Lin; Muhammad Rauf Yaqub; Zhan-Hui Zhang; Man Mao; Han-Shi Zeng; Feng-Ping Chen; Wei-Ming Li; Wen-Zhe Cai; Ying-Qiang Li; Zhi-Yong Tan; Wei Sheng; Zhi-Min Li; Xiao-Ling Tao; Yuan-Xia Li; Jun-Ping Zhang; Yao-Bin Han; Yan Li; Wu-Qiong Duan; Bao-Ni Ye; Ya-Rong Li; Yuan-Zong Song
Journal:  Transl Pediatr       Date:  2021-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.